# "Immunoregulation in Atherosclerosis: A Single-Cell RNA Sequencing Study"

> **NCT06860295** · — · NOT_YET_RECRUITING · sponsor: **Hospital Israelita Albert Einstein** · enrollment: 30 (estimated)

## Conditions studied

- Atherosclerosis of Coronary Artery

## Interventions

- **DIAGNOSTIC_TEST:** Single Cell RNA Sequencing

## Key facts

- **NCT ID:** NCT06860295
- **Lead sponsor:** Hospital Israelita Albert Einstein
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-25
- **Primary completion:** 2026-10-25
- **Final completion:** 2027-04-25
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06860295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06860295, ""Immunoregulation in Atherosclerosis: A Single-Cell RNA Sequencing Study"". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06860295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*